World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
France
2026

D-Index & Metrics

Neuroscience

D-Index
118
Citations
59007
World Ranking
403
National Ranking
9

Medicine

D-Index
119
Citations
59271
World Ranking
3855
National Ranking
113

Research.com Recognitions

  • 2026 - Research.com Neuroscience in France Leader Award
  • 2025 - Research.com Neuroscience in France Leader Award

Overview

Olivier Rascol is affiliated with the Federal University of Toulouse Midi-Pyrénées in France. Their research primarily falls within the broad field of Medicine, with a major focus on Neurology as well as contributions to Cellular and Molecular Neuroscience, Physiology, Cognitive Neuroscience, and Economics and Econometrics.

Their work covers various key topics, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Autism Spectrum Disorder Research
  • Neurological diseases and metabolism
  • Advanced Neuroimaging Techniques and Applications

Olivier Rascol has contributed numerous publications to several prominent journals. The most frequent venues for their work include:

  • Movement Disorders
  • Parkinsonism & Related Disorders
  • Journal of Parkinson's Disease
  • Neurology
  • Movement Disorders Clinical Practice

Their recent publications demonstrate a focus on Parkinson's disease and related neurological concerns. Notable papers include:

  • "LRRK2 in Parkinson disease: challenges of clinical trials," 2020, Nature Reviews Neurology
  • "Trial of Cinpanemab in Early Parkinson's Disease," 2022, New England Journal of Medicine
  • "Trial of Lixisenatide in Early Parkinson's Disease," 2024, New England Journal of Medicine
  • "Trial of Deferiprone in Parkinson's Disease," 2022, New England Journal of Medicine
  • "Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study," 2020, Neurobiology of Disease

Olivier Rascol frequently collaborates with several other researchers, among whom are:

  • Margherita Fabbri
  • Wassilios G. Meissner
  • Jean-Christophe Corvol
  • Werner Poewe
  • Joaquim J. Ferreira

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

    Christopher G. Goetz;Werner Poewe;Olivier Rascol;Cristina Sampaio

  • A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

    O Rascol;D J Brooks;A D Korczyn;P P De Deyn

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

    Klaus Seppi;Daniel Weintraub;Miguel Coelho;Santiago Perez-Lloret

  • A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

    C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin

  • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

    Alan L Whone;Ray L Watts;A Jon Stoessl;Margaret Davis

  • Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

    O Rascol;DJ Brooks;E Melamed;W Oertel

  • Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study

    U. Sabatini;K. Boulanouar;N. Fabre;F. Martin

  • Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    Paolo Barone;Werner Poewe;Stefan Albrecht;Catherine Debieuvre

  • Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).

    Gregor K. Wenning;Franc̨ois Tison;Klaus Seppi;Cristina Sampaio

  • The natural history of multiple system atrophy: a prospective European cohort study

    Gregor K Wenning;Felix Geser;Felix Geser;Florian Krismer;Klaus Seppi

  • Priorities in Parkinson's disease research

    Wassilios G Meissner;Wassilios G Meissner;Mark Frasier;Thomas Gasser;Christopher G Goetz

  • The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Unknown

  • Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease: Risk Factors forL-Dopa Induced Motor Complications

    C. Warren Olanow;Karl Kieburtz;Olivier Rascol;Werner Poewe

  • Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.

    Werner H Poewe;Olivier Rascol;Niall Quinn;Eduardo Tolosa

  • Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

    Stéphane Palfi;Jean Marc Gurruchaga;G Scott Ralph;Helene Lepetit

  • Levodopa in the treatment of Parkinson's disease: current controversies.

    C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  • Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

    Christopher G. Goetz;Werner Poewe;Olivier Rascol;Cristina Sampaio

  • Prevalence of orthostatic hypotension in Parkinson’s disease

    J M Senard;S Raï;M Lapeyre-Mestre;C Brefel

  • Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke.

    Jérémie Pariente;Isabelle Loubinoux;Christophe Carel;Jean‐François Albucher

Frequent Co-Authors

Werner Poewe
Werner Poewe Innsbruck Medical University
Jean-Louis Montastruc
Jean-Louis Montastruc Grenoble Alpes University
Wassilios G. Meissner
Wassilios G. Meissner University of Bordeaux
François Tison
François Tison University of Bordeaux
Andrew J. Lees
Andrew J. Lees University College London
Fabrizio Stocchi
Fabrizio Stocchi San Raffaele University of Rome
Robert A. Hauser
Robert A. Hauser University of South Florida
Jean-Christophe Corvol
Jean-Christophe Corvol Institut du Cerveau
Christopher G. Goetz
Christopher G. Goetz Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience can open doors to various online degree options and rewarding careers in mental health, therapy, and research fields. Many students interested in brain sciences also consider counseling or psychology as alternative or complementary pathways.

For those passionate about working in educational environments, the university of the cumberlands school counseling program offers a focused online track for aspiring school counselors. If you are looking for budget-friendly options, an affordable master's in counseling online can provide a practical route toward licensure and clinical practice.

Individuals interested in family dynamics might explore mft masters programs to become qualified marriage and family therapists. In contrast, a master’s in psychology opens diverse roles in research, therapy, or social services. Students often ask, how much does a masters in psychology cost? Tuition varies widely, making financial planning essential for future professionals.

With flexible online options and a range of specializations, neuroscience graduates can match their studies to career ambitions in both academic and applied mental health fields.

Best Scientists Citing Olivier Rascol

Trending Scientists

Recently Published Articles